254 related articles for article (PubMed ID: 31403546)
21. Systemic retinoids in chemoprevention of non-melanoma skin cancer.
Lens M; Medenica L
Expert Opin Pharmacother; 2008 Jun; 9(8):1363-74. PubMed ID: 18473710
[TBL] [Abstract][Full Text] [Related]
22. Oral retinoids for chemoprevention of skin cancers in organ transplant recipients: results of a survey.
Kovach BT; Murphy G; Otley CC; Shumack S; Ulrich C; Stasko T
Transplant Proc; 2006 Jun; 38(5):1366-8. PubMed ID: 16797305
[TBL] [Abstract][Full Text] [Related]
23. Capecitabine for skin cancer prevention in solid organ transplant recipients.
Jirakulaporn T; Endrizzi B; Lindgren B; Mathew J; Lee PK; Dudek AZ
Clin Transplant; 2011; 25(4):541-8. PubMed ID: 21050273
[TBL] [Abstract][Full Text] [Related]
24. Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients.
Endrizzi B; Ahmed RL; Ray T; Dudek A; Lee P
Dermatol Surg; 2013 Apr; 39(4):634-45. PubMed ID: 23379978
[TBL] [Abstract][Full Text] [Related]
25. Swiss clinical practice guidelines for skin cancer in organ transplant recipients.
Hofbauer GF; Anliker M; Arnold A; Binet I; Hunger R; Kempf W; Laffitte E; Lapointe AC; Pascual M; Pelloni F; Serra A;
Swiss Med Wkly; 2009 Jul; 139(29-30):407-15. PubMed ID: 19680830
[TBL] [Abstract][Full Text] [Related]
26. Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how.
Bettoli V; Zauli S; Virgili A
J Dermatolog Treat; 2013 Jun; 24(3):235-7. PubMed ID: 23148804
[TBL] [Abstract][Full Text] [Related]
27. Skin changes following organ transplantation: an interdisciplinary challenge.
Ulrich C; Arnold R; Frei U; Hetzer R; Neuhaus P; Stockfleth E
Dtsch Arztebl Int; 2014 Mar; 111(11):188-94. PubMed ID: 24698074
[TBL] [Abstract][Full Text] [Related]
28. Acitretin for prophylaxis of cutaneous malignancies after cardiac transplantation.
McNamara IR; Muir J; Galbraith AJ
J Heart Lung Transplant; 2002 Nov; 21(11):1201-5. PubMed ID: 12431493
[TBL] [Abstract][Full Text] [Related]
29. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous viral infections in organ transplant patients.
Piaserico S; Sandini E; Peserico A; Alaibac M
G Ital Dermatol Venereol; 2014 Aug; 149(4):409-15. PubMed ID: 25068228
[TBL] [Abstract][Full Text] [Related]
31. Organ transplantation and skin cancer: basic problems and new perspectives.
Hofbauer GF; Bouwes Bavinck JN; Euvrard S
Exp Dermatol; 2010 Jun; 19(6):473-82. PubMed ID: 20482618
[TBL] [Abstract][Full Text] [Related]
32. Actinic Keratosis in Solid Organ Transplant Recipients: A Medical Literature Review.
Morelló Vicente A; Oteiza Rius I; Aguado Gil L
Actas Dermosifiliogr; 2024 Apr; 115(4):368-373. PubMed ID: 37925069
[TBL] [Abstract][Full Text] [Related]
33. Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients.
Gluck M; Hodak E; Davidovici B
Dermatol Ther; 2022 Aug; 35(8):e15649. PubMed ID: 35716099
[TBL] [Abstract][Full Text] [Related]
34. Effect of acitretin on wound healing in organ transplant recipients.
Tan SR; Tope WD
Dermatol Surg; 2004 Apr; 30(4 Pt 2):667-73. PubMed ID: 15061853
[TBL] [Abstract][Full Text] [Related]
35. Interventions to Prevent Nonmelanoma Skin Cancers in Recipients of a Solid Organ Transplant: Systematic Review of Randomized Controlled Trials.
Chung EYM; Palmer SC; Strippoli GFM
Transplantation; 2019 Jun; 103(6):1206-1215. PubMed ID: 31246934
[TBL] [Abstract][Full Text] [Related]
36. Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinoma.
Martinez JC; Otley CC; Euvrard S; Arpey CJ; Stasko T;
Dermatol Surg; 2004 Apr; 30(4 Pt 2):662-6. PubMed ID: 15061852
[TBL] [Abstract][Full Text] [Related]
37. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
Harwood CA; Leedham-Green M; Leigh IM; Proby CM
Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863
[TBL] [Abstract][Full Text] [Related]
38. A long-term cohort study of acitretin for prevention of keratinocyte carcinoma in solid organ transplant recipients.
Allnutt KJ; Vogrin S; Li J; Goh MS; Brennand S; Davenport R; Chong AH
Australas J Dermatol; 2022 May; 63(2):e121-e126. PubMed ID: 35333399
[TBL] [Abstract][Full Text] [Related]
39. Systemic retinoids: chemoprevention of skin cancer in transplant recipients.
Hardin J; Mydlarski PR
Skin Therapy Lett; 2010; 15(7):1-4. PubMed ID: 20700551
[TBL] [Abstract][Full Text] [Related]
40. [Skin cancer and other skin disorders in patients following solid organ transplantation].
de Graaf YG; de Fijter JW; Posma AN; Feltkamp MC; Claas FH; Bouwes Bavinck JN
Ned Tijdschr Geneeskd; 2005 Mar; 149(10):511-7. PubMed ID: 15782685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
